Could cause temporary or reversible harm; serious harm is unlikely.
Presence of foreign tablets/capsules: presence of foreign Divalproex Sodium Extended-Release 250mg tablet in a bottle of omeprazole capsules.
| Brand name | OMEPRAZOLE |
| Generic name | OMEPRAZOLE |
| Active ingredient(s) | OMEPRAZOLE |
| Distributed by / for | Qualient Pharmaceuticals Health LLC, Grand Cayman, Cayman Islands |
| NDC | 82009-022-10 |
| Full product label | Omeprazole Delayed-release Capsules, USP, 20mg, 1000-count bottle, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA, Manufactured for: Qualient Pharmaceuticals Health LLC, Grand Cayman, Cayman Islands, NDC 82009-022-10. NDC 82009-022-10 |
| Recalling firm | Dr. Reddy's Laboratories, Inc. |
| Distribution | USA Nationwide |
| Quantity | 1476 bottles |
| Recall initiated | 2025-06-30 |
| Report date | 2025-07-23 |
| Recall completed | — |
| Recall number | D-0525-2025 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗